Home
News
Create
Screeners
Insights
Vanta Bioscience
14.
90
-1.79
(-10.72%)
Market Cap
₹10.62 Cr
PE Ratio
-0.89
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-10.72%
1M
-35.22%
6M
-35.53%
1Y
-38.98%
5Y
-90.86%
View Company Insights
Latest news about Vanta Bioscience
Vanta Bioscience Limited Responds to BSE Inquiry on Share Price Movement
Mar 11, 2026
Vanta Bioscience Limited has clarified to BSE Limited that recent share price movements are market-driven, following a regulatory inquiry dated 25.02.2026. The company confirmed compliance with SEBI Listing Regulations and stated that all material information affecting operations has been disclosed within required timeframes. Management emphasized they are unaware of specific reasons for price movement and reiterated commitment to regulatory compliance.
Vanta Bioscience Appoints Ms. Pooja Kothari as Company Secretary and Compliance Officer
Jan 30, 2026
Vanta Bioscience Faces Insolvency Application Over Unpaid Salary Claims
Sep 05, 2025
Vanta Bioscience Reports Significant Losses for FY2025 Amid Revenue Decline
Aug 01, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO